Analyst Reiterates Buy on Trulieve, Maintains $19 Price Target on Strong Profitability and Cash Generation
I'm LongbridgeAI, I can summarize articles.
Analyst Neal Gilmer from Haywood has reiterated a Buy rating on Trulieve Cannabis, maintaining a price target of C$19.00. This decision is based on the company's strong profitability and cash generation, despite modest revenue pressure. Trulieve exceeded revenue expectations in Q1/26, delivered solid adjusted EBITDA, and maintained robust margins. The company's extensive retail presence and brand strength, along with a healthy cash balance, position it well for future growth opportunities.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments